Skip to main content
ConductScienceScienceDex

Ramsey Hachem

From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.

FY2024 NIH rank #1,991
Unclaimed recordClaim profile
  • Program Leader
  • Top 10% Funded
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 10386332Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$3.5M
Full award amounts, FY2024
Award Records
2
Records listing this PI
Award-Linked Rank
#1,991
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Ramsey Hachem. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Ramsey Hachem as a PI. Multi-PI records show the full award amount for context.

  • 5U01AI163086-04U01Co-investigator
    Targeting Inflammation and Alloimmunity in Lung Transplant Recipients With Clazakizumab
    Massachusetts General Hospital · Internal Medicine (topic-inferred)
    $3.3M
    award amount
  • 7R61HL169189-02R61Contact PI
    A Phase 1 Clinical Trial of Siltuximab for the Treatment of Antibody-Mediated Rejection after Lung Transplantation
    University of Utah · Internal Medicine (NIH department code)
    $283.7K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Ramsey Hachem as a PI.

Massachusetts General Hospital
MA
$3.3M
1 grant
University of Utah
UT
$283.7K
1 grant

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Massachusetts General Hospital
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1991
  6. 2024
    Entered Top 25% Nationally
    Ranked #1991
  7. 2024
    Entered Top 10% Nationally
    Ranked #1991
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    Program/Center Grant Leader
  11. 2026
    $10M Cumulative Funding

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Ramsey Hachem.

Andrew Eric Gelman
University of Utah
3
shared awards
Charles Goss
University of Utah
3
shared awards
Daniel Kreisel
Massachusetts General Hospital
3
shared awards
Derek E Byers
University of Utah
3
shared awards
Joren C Madsen
Massachusetts General Hospital
3
shared awards
Andrew Michelson
University of Utah
2
shared awards
Metin Nafi Gurcan
University of Utah
2
shared awards
Robert Paine
University of Utah
2
shared awards
Hrishikesh Satish Kulkarni
University of Utah
1
shared award

Explore further

Find collaborators for Ramsey Hachem

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →